- Home
- NIM vs ME Comparison
NIM vs ME Comparison
Compare NIM & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIM
- ME
- Stock Information
- Founded
- NIM 1992
- ME 2006
- Country
- NIM United States
- ME United States
- Employees
- NIM N/A
- ME N/A
- Industry
- NIM Trusts Except Educational Religious and Charitable
- ME Precision Instruments
- Sector
- NIM Finance
- ME Health Care
- Exchange
- NIM Nasdaq
- ME Nasdaq
- Market Cap
- NIM 115.9M
- ME 113.9M
- IPO Year
- NIM N/A
- ME N/A
- Fundamental
- Price
- NIM $8.90
- ME $3.11
- Analyst Decision
- NIM
- ME Hold
- Analyst Count
- NIM 0
- ME 1
- Target Price
- NIM N/A
- ME $9.40
- AVG Volume (30 Days)
- NIM 35.4K
- ME 452.5K
- Earning Date
- NIM 01-01-0001
- ME 11-12-2024
- Dividend Yield
- NIM 3.46%
- ME N/A
- EPS Growth
- NIM N/A
- ME N/A
- EPS
- NIM N/A
- ME N/A
- Revenue
- NIM N/A
- ME $193,260,000.00
- Revenue This Year
- NIM N/A
- ME $21.93
- Revenue Next Year
- NIM N/A
- ME $17.31
- P/E Ratio
- NIM N/A
- ME N/A
- Revenue Growth
- NIM N/A
- ME N/A
- 52 Week Low
- NIM $8.28
- ME $2.66
- 52 Week High
- NIM $9.74
- ME $20.40
- Technical
- Relative Strength Index (RSI)
- NIM 31.96
- ME 30.62
- Support Level
- NIM $8.87
- ME $2.66
- Resistance Level
- NIM $9.02
- ME $3.58
- Average True Range (ATR)
- NIM 0.09
- ME 0.45
- MACD
- NIM -0.01
- ME -0.08
- Stochastic Oscillator
- NIM 10.28
- ME 16.90
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital by investing in an investment-grade quality portfolio of municipal obligations with intermediate characteristics.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.